CRH plc (CRH): Among Stocks with Buy Ratings that Hedge Funds Love
We recently published a list of . In this article, we are going to take a look at where CRH plc (NYSE:CRH) stands against other stocks with buy ratings that hedge funds love.
The U.S. stock market has been in chaos ever since President Trump announced his intent to increase tariffs on the U.S.'s trading partners. On April 2, 2025, the President officially presented the new tariff rates, calling them reciprocal tariffs. Since the presentation, the value of the U.S. stock market has started plunging. Though these tariffs have led to bloodbaths in many exchanges across the globe, the impact is heavy in the U.S. market where it originated.
China, one of the largest trading partners of the U.S., retaliated against the new tariff by slapping a 34% levy on U.S. goods, thus igniting a global trade war. The result? A $9 trillion wipeout in U.S. equity markets, according to CNBC. Experts are calling it the worst weekly performance since the COVID-19 crash.
READ ALSO: .
Retail investors are scrambling for the exits to protect their investments. However, hedge funds are quietly loading up on bargains. Analysts are perceiving an opportunity in the turmoil, and institutional investors are using the downturns to pepper their portfolios with high-conviction stocks at fire-sale prices. Right now, their buy lists are flashing green. They do not back the stocks unquestioningly, however, they look at the fundamentals, pricing power, and growth trends of the stocks to estimate their ability to outlast the storm.
If there is one thing we can learn from history, it is that markets often make their most significant rebounds after their steepest declines. When discussing the significance of virtues like patience and calmness in an investor during turmoil, a billionaire investor quoted a 19th-century poem: 'If you can keep your head when all about you are losing theirs… yours is the Earth and everything in it.' His point? Panic is expensive. On the other hand, opportunity can be priceless when accumulating institutional interest signals to investors where to look.
This brings us to the heart of our article today. Combining hedge fund filings, analyst upgrades, and real-time market data, we have uncovered 15 stocks with Buy ratings, which could potentially refine your portfolio. Top hedge funds are piling into these stocks, making them more appealing to investors interested in generating income.
But don't just take our word for it. History has given us a few examples to consider before making investment decisions. For instance, the 2020 pandemic crash is a prime example of how hedge fund portfolios can be better performers than the market index. Following the crash, hedge fund-backed stocks outperformed the market indexes by 14% in 2021. It indicates that institutional conviction can be louder than the market's noise.
We put together our list of 15 stocks by primarily considering the Buy ratings of the stocks. Our list included only those stocks with a strong Buy rating, as we see it as a crucial component for investors to make informed decisions. Another factor we considered was the hedge fund sentiment toward these stocks, according to Insider Monkey's Q4 2024 database. It indicated the level of institutional interest in the stock. The value of hedge funds has also been used to rank the stocks on our list, with the top stock having the highest value of hedge funds.
Additionally, we filtered our list by excluding stocks with negative earnings per share (EPS) over the past five years. We regarded those stocks with a positive EPS since it reflects consistency in profitability. All the data used in the article were taken from financial databases and analyst reports, with all information current as of April 5, 2025.
Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter's strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points ().
A construction worker wearing a hard hat and safety glasses at a site, carrying concrete blocks.
One of the leading manufacturers and distributors of building materials, CRH plc (NYSE:CRH), operates in North America and Europe. The company is headquartered in Ireland and offers cement, aggregates, asphalt, and ready-mixed concrete to infrastructure, commercial, and residential construction markets. The company competes with competitors like Heidelberg Materials and Holcim for market share by gaining a competitive advantage through vertical integration and strategic acquisitions. CRH plc earned the position as an efficient supplier in the cyclical market by meeting the sustainability-driven demand for lower-carbon materials.
Attracting 90 hedge funds from the Insider Monkey Q4 2024 database, CRH plc (NYSE:CRH) has amassed $6.61 billion in investments. By the end of the financial year 2024, the company announced an industry-leading performance, with the revenue experiencing a 2% growth, reaching $35.6 billion. 40 value-accretive acquisitions in 2024 garnered an investment of $5 billion from the company. CRH reported that these acquisitions have been crucial to the company's growth as a market leader. They also announced a 6% increase in dividends per share, marking the 40th consecutive year of growth. For 2025, the company expects continued growth and value creation, attributed to the infrastructure activity in Europe and North America.
CRH plc (NYSE:CRH) leads in the construction materials sector, as reflected by its 18.51% EPS growth over five years despite strong competition prevailing in the market. Analysts' confidence in the company's market presence remains high, as represented by their Strong Buy rating.
Overall, CRH ranks 3rd on our list of stocks with buy ratings that hedge funds love. While we acknowledge the potential for CRH as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. There is an AI stock that went up since the beginning of 2025, while popular AI stocks lost around 25%. If you are looking for an AI stock that is more promising than CRH but trades at less than 5 times its earnings, check out our report about this .
READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires.
Disclosure: None. This article is originally published at Insider Monkey.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
21 minutes ago
- Yahoo
May CPI: Inflation pressures ease on a monthly basis as tariff uncertainty lingers
May's Consumer Price Index (CPI) report showed inflation pressures eased on a monthly basis as investors closely watch for any signs that President Trump's tariffs are impacting what consumers pay. The latest data from the Bureau of Labor Statistics showed that the Consumer Price Index (CPI) increased 0.1% month over month, below April's 0.2% rise and a beat compared to economists' estimates of a 0.2% monthly gain in prices. Yearly CPI rose 2.4% in May, a slight uptick from April's 2.3% uptick, which marked the lowest yearly increase since February 2021. On a "core" basis, which excludes volatile food and energy costs, CPI rose 2.8% over the past year in May, matching April. Monthly core prices increased 0.1%, a touch below April's 0.2% gain. Heading into the report, economists had expected core CPI to rise 2.9% year over year and 0.3% month over month. Declines in car and apparel prices, categories expected to show some of the earliest impacts from tariffs, helped drive a cooler-than-expected core CPI reading last month. The report reflects the time period about a month after Trump's "Liberation Day" tariff announcements shook markets and businesses. Since then, many of those "reciprocal" tariffs have been paused, but the 10% baseline duties for most countries remain in place. Mexico and Canada continue to face fentanyl-related tariffs, and industry-specific tariffs on steel, aluminum, and autos remain unchanged. Tariffs on China are still significant even as a truce temporarily pauses big hikes, with the effective tariff rate on Chinese goods hovering around 30%. Early Wednesday, the US and China agreed to a framework and implementation plan aimed at easing tariff and trade tensions. President Trump signaled his approval, saying the deal was "done," pending final sign-off from him and Chinese President Xi Jinping. Core inflation has remained stubbornly elevated due to sticky costs for shelter and services like insurance and medical care. The shelter index rose 3.9% over the last year and 0.3% over the prior month in May. It was the primary factor in the all items monthly increase, according to the BLS. The index for rent and owners' equivalent rent (OER) rose 0.2% and 0.3%, respectively, over the prior month. Owners' equivalent rent is the hypothetical rent a homeowner would pay for the same property. Still, there were signs of easing within shelter. Lodging away from home, for instance, fell 0.1% in May. Outside of shelter, the downside surprise in core inflation was also aided by other categories, including a drop in airline fares, used cars and trucks, new vehicles, and apparel. Meanwhile, the energy index dropped 1% month over month after rising 0.7% in April. On a yearly basis, the energy index was down 3.5%, aided by falling gas prices, which dropped 12% year over year in May. Notably, food prices reversed last month's easing, with the index rising 0.3% last month after a 0.1% decline in April. Egg prices dropped 2.7% from April to May but still remain near historic highs. On a yearly basis, egg prices have climbed around 41.5%. Other indexes with notable increases over the last year include medical care (+2.5%), motor vehicle insurance (+7.0%), household furnishings and operations (+2.7%), and recreation (+1.8%). This is a breaking news report. Stay tuned for updates. Allie Canal is a Senior Reporter at Yahoo Finance. Follow her on X @allie_canal, LinkedIn, and email her at Sign in to access your portfolio
CBS News
22 minutes ago
- CBS News
Trump says U.S. trade "deal with China is done," after tariff talks yield "framework deal"
London — President Trump declared on Wednesday morning that a U.S. trade "deal with China is done." The U.S. leader offered a few key details of a "framework deal" reached between senior U.S. and Chinese trade representatives in London on Tuesday, but he acknowledged that both he and Chinese President Xi Jinping were both yet to formally sign off on the agreement. The U.S. and Chinese trade teams wrapped up two days of marathon negotiations in London close to midnight on Tuesday, with the sides saying they had agreed on a new "framework deal" to ease the trade war between the world's two largest economies. The tension had only increased in recent weeks, despite an agreement reached in Geneva during a first round of talks in May to put the steepest retaliatory tariffs on hold. Those record-high tariffs are due to kick back in on July 9, unless the agreement struck in London is in fact formalized by Trump and Xi. In month since the Geneva talks, Beijing had cut its exports of critical rare earth elements to the U.S. by half compared to the previous year, and the Trump administration said it would "aggressively revoke" the visas of Chinese students in the U.S. who were found to be linked to the Chinese Communist party. While the announcement by Mr. Trump's top negotiators on Tuesday evening of an agreed framework was thin on details, the president said in a post on his own Truth Social media platform Wednesday morning that it was "done, subject to final approval with president Xi and me." He said the deal would see China maintain its current 10% tariffs on goods imported from the U.S., while the U.S. would keep 55% tariffs on Chinese imports. There was no immediate confirmation from China's government of any terms agreed to in the framework, or whether President Xi intended to sign off on the deal. In Geneva, Beijing and Washington agreed in May to put their unprecedented tariffs of more than 100% on each other's imports on hold for 90 days. That brought U.S. tariffs on Chinese imports down to their current level of 30% after they briefly soared to around 145%. Chinese tariffs currently stand at 10%, after hitting 125% before the Geneva round of talks. Speaking Tuesday, Vice Commerce Minister Li Chenggang, who took part in the talks in London, confirmed the agreement on a framework, "in principle." On Wednesday, China's state-run media said the delegations had "made new progress," but offered no details. "The framework deal puts meat on the bones of an agreement reached last month in Geneva to ease bilateral retaliatory tariffs," U.S. Commerce Secretary Howard Lutnick told reporters after the talks in London, which spanned six hours on Monday and then more than 12 hours into the evening on Tuesday. Lutnick said part of the objective of this week's second round of meetings was just to get "the negativity out" of the bilateral relationship, which had festered since the Geneva talks. "Now we can go forward to try to do positive trade, growing trade," he said. The U.S. wants China to resume and increase shipments of rare earths. The materials are vital to industries ranging from weapons and aerospace to electric vehicles and small consumer goods. On Wednesday, in his all-capital-letter social media post, Mr. Trump said under the agreement reached in London, "full magnets, and any necessary rare earths, will be supplied, up front, by China. Likewise, we will provide to China what was agreed to, including Chinese students using our colleges and universities." "Relationship is excellent!" added Mr. Trump. "At stake is the release of rare earths exports to U.S. manufacturers — stockpiles are dwindling fast — in exchange for aerospace parts and semiconductor programming technology to China," Carl Weinberg, chief economist at High Frequency Economics, told investors in a report. "A 'fail' would raise the risk of auto and aircraft production grinding to a halt as soon as next month. If that happens, economic growth will be severely dented for an unknown term."
Yahoo
22 minutes ago
- Yahoo
Herbalife's Aloin Identification Method for Aloe Vera Officially Recognized by AOAC INTERNATIONAL
Certified Method Enhances Global Botanical Quality and Safety LOS ANGELES, June 11, 2025--(BUSINESS WIRE)--Herbalife Ltd. (NYSE: HLF), a premier health and wellness company, community and platform, today announced the Association of Official Analytical Collaboration (AOAC INTERNATIONAL)—a global authority in analytical science—has formally certified its proprietary method for identifying and measuring anthraquinones, also known as aloins, in aloe vera. Aloe regulatory groups require producers of ingestible aloe vera products to monitor naturally occurring compounds such as aloin A, aloin B, and aloe-emodin to meet safety guidelines. This certification officially recognizes Herbalife's longstanding method as the world's first AOAC-approved approach for detecting aloins—reinforcing safety and quality benchmarks across botanical and dietary supplement industries. Developed by Herbalife scientists and validated by independent laboratories worldwide, this AOAC-certified method is used to test every batch of Herbalife's aloe-based products, ensuring safety, while preserving aloe vera's natural benefits. Aloe vera is a key ingredient in many of Herbalife's top products, which are sold in more than 90 markets. "This AOAC validation is an important milestone for Herbalife and the industry as a whole," said Gary Swanson, SVP of Global Quality at Herbalife and lead author of the study. "We are proud to lead scientific innovation that enhances botanical ingredient safety, benefitting not only Herbalife products and our customers, but also advancing standards across the industry." Herbalife's method was validated through a global multi-laboratory study involving eight independent laboratories. Each lab tested the same set of six aloe vera samples, including both raw materials and finished products, using HPLC (High-Performance Liquid Chromatography) to measure aloin A, aloin B, and aloe-emodin. The study ensured the method's accuracy and reliability across various labs and product types, with results confirming that it met all performance criteria, including precision and system suitability. "This multi-laboratory validation study supported approval of an analytical method developed by Herbalife scientists as the AOAC 2016.09 Official Final Action Method," said Dr. Katerina Mastovska, deputy executive director and chief science officer, AOAC INTERNATIONAL. "AOAC official methods undergo rigorous scientific evaluation and are highly credible and globally accepted. As such, this method will help strengthen botanical quality and safety standards worldwide." Herbalife has a long-standing commitment to aloe vera research and quality assurance. This dedication has resulted in five patents and three published studies focused on developing safe extraction methods that preserve the plant's natural benefits. While many companies rely solely on supplier certifications to confirm the authenticity of their aloe vera, Herbalife goes further. The company is one of the few in the world using advanced proton nuclear magnetic resonance (NMR) spectrometry—an analytical technique that uses magnetic fields and radio waves to identify the molecular structure of raw materials. This allows Herbalife to independently verify the identity and purity of its aloe vera at the molecular level, ensuring the highest standards of quality, consistency and traceability across its global supply chain. For 45 years, Herbalife has upheld a global commitment to quality through its rigorous Seed to Feed process. This comprehensive system ensures that every ingredient—from responsibly sourced crops cultivated by dedicated farmers to the finished product—meets stringent standards for identity, potency, safety, and purity. Herbalife performs internal testing in ISO 17025-accredited laboratories, verifying that ingredients comply with both company standards and government regulations. The company's science-backed approach, grounded in Good Manufacturing Practices (GMPs) and NSF International standards, delivers consistent, transparent products in more than 90 markets. Supported by a global team of scientists and quality experts, this process strengthens consumer trust and continues to advance industry standards worldwide. Herbalife's aloe vera testing method has been published in Journal of AOAC INTERNATIONAL (Volume 108, Issue 3, Pages 449-471). About Herbalife Ltd. Herbalife (NYSE: HLF) is a premier health and wellness company, community and platform that has been changing people's lives with great nutrition products and a business opportunity for its independent distributors since 1980. The Company offers science-backed products to consumers in more than 90 markets through entrepreneurial distributors who provide one-on-one coaching and a supportive community that inspires their customers to embrace a healthier, more active lifestyle to live their best life. For more information, visit View source version on Contacts Media Contact: media@
